PMID: 9450808Feb 5, 1998Paper

Very low incidence of p53 antibodies in adult non-Hodgkin's lymphoma and multiple myeloma

British Journal of Haematology
C PreudhommeP Fenaux

Abstract

In several types of solid tumours, circulating antibodies to p53 are seen in about a third of cases with a p53 mutation, but are absent in cases without p53 mutation. Therefore detection of those antibodies has relatively low sensitivity but high specificity in the detection of p53 mutations. We looked for circulating p53 antibodies by ELISA in 56 adult non-Hodgkin's lymphoma (NHL) and 80 multiple myeloma cases. A certain or highly probable p53 mutation was found by SSCP analysis, immunocyto- or immunohistochemistry in 8/35 (23%) NHL cases and 2/19 (10%) MM cases analysed by these techniques. None of the 80 MM cases and only one of the 56 cases of NHL had circulating p53 antibodies. The positive case had Burkitt's lymphoma and a p53 missense mutation at codon 273. Thus, very few MM and NHL patients with a p53 mutation develop p53 antibodies and this test does not appear to be useful in haematological malignancies.

References

Jul 1, 1992·British Journal of Haematology·C PreudhommeP Fenaux
Feb 15, 1987·International Journal of Cancer. Journal International Du Cancer·C Caron de FromentelP May
Jul 1, 1995·British Journal of Cancer·D J AdamsonN E Haites
Jun 22, 1995·International Journal of Cancer. Journal International Du Cancer·C P WildH Vainio

❮ Previous
Next ❯

Citations

Aug 23, 2011·The American Journal of Pathology·Ruben van BoxtelEdwin Cuppen

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.